The mistake I see constantly: people assume the cheapest monthly price equals the cheapest program. It usually does not. A $99 headline rate with vague pharmacy sourcing, no overnight shipping, or mandatory annual coaching bundles can cost more in practice than a slightly pricier plan that actually includes everything up front.
Here is what I found after going through the fine print on more than a dozen telehealth GLP-1 programs in 2026.
Quick Context
The GLP-1 telehealth space shifted hard in early 2026. The FDA issued warning letters to over 30 compounding-related firms, and a Novo Nordisk settlement in March pushed several big platforms off compounded semaglutide entirely. That reshuffling created real winners and losers on price. Compounded semaglutide is not FDA-approved, but for cash-pay patients, it remains the most affordable entry point where it is still legally available.
The 5 Programs Worth Your Attention
1. HealthRX
The single thing that moved HealthRX to the top of my list: compounded semaglutide at $99 per month with free overnight shipping to all 50 states, and the medication comes from a named 503A pharmacy, Manifest Pharmacy in Greer, South Carolina, operating under USP-797 standards with lot-tracked batches. You know exactly where the vial originated.
Physician review runs roughly 24 hours after your online intake. No annual contract requirement, no hidden platform fees baked into a second invoice.
Best for: Cash-pay patients who want the lowest entry price, verifiable pharmacy sourcing, and fast delivery anywhere in the country.
Honest con: Compounded semaglutide is not FDA-approved, and like all compounding programs, it carries regulatory uncertainty that branded products do not.
2. FormBlends
FormBlends sits at a higher price point than HealthRX, with semaglutide around $299 per vial and tirzepatide around $349, so it is not the budget pick. What earns it the second slot is transparency most programs skip entirely: published purity testing per product, including HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin sterility results with named numbers. If you want to see the actual data behind what you are injecting, this is the only program in this list that shows it.
The clinician model is the same general telehealth structure, and the pharmacy is an FDA-registered 503A facility. Ships to 47 states, not all 50. FormBlends also carries a broad catalog of peptides for recovery, longevity, and cognitive goals under the same physician-overseen model, which none of the GLP-1-only platforms offer.
Best for: Patients who prioritize documented purity testing, or anyone who wants GLP-1 medication alongside other peptide protocols from one provider.
Honest con: Per-vial pricing runs 2 to 3 times higher than HealthRX’s entry rate. Smaller state coverage too.
3. Mochi Health
Mochi uses board-certified obesity-medicine physicians, which is a real differentiator from general-practice telehealth. Compounded semaglutide is around $99 per month and tirzepatide around $199. The monitoring is more involved than most cash-pay platforms, meaning more check-ins and a longer onboarding. Some patients want that. Others find it slower.
Best for: People who want obesity-medicine-specialist oversight rather than a general practitioner sign-off.
Honest con: Tirzepatide pricing is noticeably higher than some competitors.
4. Henry Meds
Henry Meds keeps it simple: cash-pay compounded GLP-1s, no insurance involvement, fast shipping in 24 to 72 hours, and pricing that starts around $179 to $249 for the first month. The monitoring is lighter than Mochi. No long-term contracts.
Best for: Someone who wants a straightforward cash-pay experience and reasonably quick turnaround without heavy clinical hand-holding.
Honest con: Lighter monitoring may not suit patients who are new to injectables or who have more complex health histories.
5. Hims & Hers
After exiting compounded GLP-1s following the March 2026 Novo settlement, Hims & Hers now sells branded medications. Injectable Wegovy runs around $299 per month through their platform, with Zepbound around $399. With insurance and a savings card, costs can drop to single digits. That insurance pathway is the real value here.
Best for: Insured patients who can apply a savings card and potentially pay almost nothing out of pocket.
Honest con: Without insurance, the cash price is significantly higher than any compounded option on this list.
A Note Before You Decide
None of this is medical advice. Semaglutide and tirzepatide are prescription medications with real side effects, and compounded versions are not FDA-approved products. Prices change, program availability shifts by state, and what worked for someone else may not suit your situation. Talk to a physician who knows your full health history before starting any GLP-1 program.
Common Questions
Does HealthRX’s $99 monthly price actually include everything, or are there fees stacked on top?
Based on published pricing as of May 2026, the $99 rate at HealthRX includes the compounded semaglutide, the physician intake review, and free overnight shipping. No separate platform fee or coaching bundle is required. That all-in structure is specifically why it ranks first here, since most programs advertise a medication price and bill separately for clinical services.
Why does FormBlends cost so much more than the other compounded options if it uses the same general telehealth model?
The price difference reflects the published third-party lab testing FormBlends provides per product batch, including HPLC purity percentages and endotoxin results with actual numbers attached. You are partly paying for that documentation. Whether that transparency justifies spending 2 to 3 times more than HealthRX’s rate depends entirely on how much verified purity data matters to your decision.
Can Hims & Hers still get me compounded semaglutide after the March 2026 Novo settlement?
No. Hims & Hers exited compounded GLP-1s following that settlement and now offers only branded medications, Wegovy and Zepbound, through its platform. If you specifically want compounded semaglutide, you would need to look at HealthRX, FormBlends, Mochi Health, or Henry Meds instead, provided your state permits compounded GLP-1 access.
Is the obesity-medicine oversight at Mochi Health meaningfully different from what HealthRX or Henry Meds offers?
It can be. Board-certified obesity-medicine physicians have specialized training in weight physiology, medication titration, and comorbidity management that a general telehealth practitioner may not. The trade-off is a slower, more involved onboarding. For patients with complex histories or prior GLP-1 side effects, that extra layer is worth considering seriously.
If I live in one of the three states FormBlends does not ship to, which program is the next best option for purity transparency?
None of the other four programs on this list publish batch-level lab data at FormBlends’ level of detail. HealthRX names its pharmacy and references USP-797 and lot-tracking, which is more sourcing transparency than most. That is a meaningful step, but it is not the same as published HPLC percentages. Your realistic alternative is asking any program directly for their pharmacy’s certificate of analysis before ordering.
Sources
- FDA warning letters to compounding pharmacies and telehealth firms, Q1 2026 (FDA.gov)
- A randomized controlled trial of tirzepatide in adults with obesity, published in NEJM in 2022 and authored by Jastreboff and colleagues
- A phase 3 randomized trial of semaglutide for weight management, published in NEJM in 2021 and authored by Wilding and colleagues
- Novo Nordisk settlement reporting, March 9 2026 (Reuters, STAT News)
- LillyDirect orforglipron pricing announcement, April 2026 (Eli Lilly press release)
- Individual platform pricing pages reviewed May 2026
